Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round

May 15, 2018 8:21 am Published by Leave your thoughts

PALO ALTO, Calif. – (Business Wire) – Genoox, a genomic analysis company making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications, today announced it closed a $6 million funding round. The round was led by Triventures, a venture capital fund that invests in transformational health startups led by elite teams and is focused on impacting the quality, cost and experience of healthcare. The investment was joined by Inimiti Capital and Glilot Capital Partners.

Categorised in:

This post was written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *